Computational analysis reveal inhibitory action of nimbin against dengue viral envelope protein
Tóm tắt
Dengue has emerged to be global health problem worldwide. Hence there is an immediate need to adopt new strategies in the development of effective anti-dengue drugs. Extracts from the leaves of Azadirachta indica has been traditionally used in folk medicine for viral infections. In the present study we report the anti-viral potency of nimbin, the active compound from the neem leaf extract against the envelope protein of dengue virus. Progression of viral entry into the host cell is facilitated by the envelope protein of dengue virus, suggesting; it as an effective anti-viral target. Nimbin is found to be effective against the envelope protein of all four types of dengue virus (dengue 1–4), which is evident from our in silico analysis. Our findings suggest the clinical importance of nimbin, which can serve as effective lead compound for further analysis.
Tài liệu tham khảo
Alavijeh MS, Chishty M, Palmer AM. Drug metabolism and pharmacokinetics, the blood–brain barrier, and central nervous system drug discovery. NeuroRx. 2005;2:554–71.
Badam L, Joshi SP, Bedekar SS. In vitro antiviral activity of neem (Azadirachta indica, A. Juss) leaf extract against group BCoxsackie viruses. J Commun Dis. 1999;31:79–90.
Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 2005;78:431–41.
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyallow IN, Bourne PE. The Protein data bank. Nucleic Acid Res. 2000;28:235–42.
Braga RC, Alves VM, Silva MFB, Muratov E, Fourches D, Tropsha A, Andrade CH. Tuning hERG out: antitarget QSAR models for drug development. Curr Top Med Chem. 2014;14:1399–415.
Braga RC, Alves VM, Silva MFB, Muratov E, Fourches D, Liao LM, Tropsha A, Andrade CH. Pred-hERG: a novel web-accessible computational tool for predicting cardiac toxicity. Mol Inf. 2015;. doi:10.1002/minf.201500040.
Chattopadhyay D, Sarkar MC, Chatterjee T, Dey SR, Bag P, Chakraborti S, Khan MT. Recent advancements for the evaluation of anti-viral activities of natural products. N Biotechnol. 2009;25:347–68.
Chaturvedi PR, Decker CJ, Odinecs A. Prediction of pharmacokinetic properties using experimental approaches during early drug discovery. Curr Opin Chem Biol. 2001;5:452–63.
Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW, Tang Y. admetSAR: a comprehensive source and free tool for evaluating chemical ADMET properties. J Chem Inf Model. 2012;52:3099–105.
Cleves AE, Jain AN. Effects of inductive bias on computational evaluations of ligand-based modeling and on drug discovery. J Comput Aided Mol Des. 2008;22:147–59.
Cockburn JJ, Sanchez NME, Fretes N, Urvoas A, Staropoli I, Kikuti CM, Coffey LL, Seisdedos FA, Bedouelle H, Rey FA. Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. Structure. 2012;20(2):303–14.
Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput Aided Mol Des. 1997;11:425–45.
Figueiredo MAA, Rodrigues LC, Barreto ML, Wellington JO, Costa MCN, Morata V, Vasconcelos PFC, Nunes MRT, Teoxeora MG. Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study. PLoS Negl Trop Dis. 2010;4:e699.
Frimayanthi N, Chee CF, Zain SM, Rahman NA. Design of new competitive dengue Ns2b/Ns3 protease inhibitors—a computational approach. Int J Mol Sci. 2011;12:1089–100.
Ghimeray AK, Jin C, Ghimire BK, Cho DH. Antioxidant activity and quantitative estimation of azadirachtin and nimbin in Azadirachta Indica A. Juss grown in foothills of Nepal. Afri. J Biol. 2009;8:3084–91.
Goswami RP, Mukherjee A, Biswas T, Karmakar PS, Ghosh A. Two cases of dengue meningitis: a rare first presentation. J Infect Dev Ctries. 2012;6:208–11.
Gupta N, Srivastava S, Jain A, Chaturvedi UC. Dengue in India. Indian J Med Res. 2012;136:373–90.
Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martínez ES, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8:S7–16.
Hermann EC, Muccra J, Kucera LS. Antiviral substances in plants of the mint family (Labiatae). Proc Soc Exp Biol Med. 1967;124:865–74.
Hesse R. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology. 1990;174:479.
Huttunen KM, Raunio H, Rautio J. Prodrugs—from serendipity to rational design. Pharamacol Rev. 2011;63:750–71.
Inoue M, Morikawa M, Tsuboi M, Yamada T, Sugiura M. Hydrolysis of ester-type drugs by the purified Esterase from human intestinal mucosa. Jpn J Pharmacol. 1979;29:17–25.
Jain AN. Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities. J Comput Aided Mol Des. 1996;10:427–40.
Jain AN. Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J Med Chem. 2003;46:499–511.
Jain AN. Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J Med Chem. 2003;46:499–511.
Ji HF, Li XJ, Zhang HY. Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep. 2009;10:194–200.
Johari J, Kianmehr A, Mustafa MR, Abubakar S, Zandi K. Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus. Int J Mol Sci. 2012;13:16785–95.
Jones G, Willett P, Glen RC. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol. 1995;245:43–53.
Kamb KM, Amoral M, Girre L. Search for non-antiviral agents of plant origin. Pharmacol Acta Helv. 1992;67:130–47.
Keller TH, Pichota A, Yin Z. A practical view of ‘druggability’. Curr Opin Chem Biol. 2006;10:357–61.
Kerns EH, Di L. Drug-like properties: concepts, structure design and methods—from ADMET to toxicity optimization. 1st ed. London: Academic Press; 2010. p. 426–38.
Lin JH. Role of P-glycoprotein in pharmacokinetics clinical implications. Clin Pharmacokinet. 2003;42:59–98.
Meng EC, Shoichet BK, Kuntz ID. Automated docking with grid-based energy evaluation. J Comput Chem. 1992;13:505–24.
Mitchell MJ, Smith SL, Johnson S, Morgan ED. Effects of the neem tree compounds azadirachtin, salannin, nimbin, and 6-desacetylnimbin on ecdysone 20-monooxygenase activity. Arch Insect Biochem Physiol. 1997;35:199–209.
Modis Y, Ogata S, Clements D, Harrison SC. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol. 2005;79(2):1223–12231.
Molinspiration Cheminformatics, Bratislava, Slovak Republic. www.molinspiration.com/services/properties.html. Accessed Sept 2013.
Palm K, Stenberg P, Luthman K, Artursson P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm Res. 1997;14:568–71.
Pardridge WM. CNS drug design based on principles of blood–brain barrier transport. J Neurochem. 1998;70:1781–92.
Parida MM, Upadhyay C, Pandya G, Jana AM. Inhibitory potential of neem (Azadirachta indica Juss) leaves on dengue virus type-2 replication. J Ethnopharmacol. 2002;79:273–8.
Patrick GL. An introduction to medicinal chemistry. New York: Oxford University Press; 2001.
Plasencia C, Dayam R, Wang Q, Pinski J, Burke TR, Quinn DI, Neamati N. Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines. Cancer Ther. 2005;4:110.
Pramely R, Raj TLS. Prediction of biological activity spectra of a few phytoconstituents of Azadirachta indicia Juss. J Biol Technol. 2012;3:375–9.
Rai AR, Sethi M. Screening of some plants for their activity against vaccinia and fowl pox viruses. Indian J Anim Sci. 1972;42:1066–70.
Rao AR, Kumar SSV, Paramsivam TR, Kamalakshi S, Parashuraman AR, Shanta B. Study of antiviral activity of leaves of margosa tress on vaccinia and variola viruses—a preliminary report. Indian J Med Res. 1969;57:495–502.
Reddy AB, Sethi MS. Antiviral effects of some indigenious plant extracts on vaccinia and fowl pox viruses on chick embryo fibroblasts. Indian J Exp Biol. 1974;12:572–9.
Rees DC, Congreve M, Murray CW, Carr R. Fragment-based lead discovery. Nat Rev Drug Discov. 2004;3:660–72.
Sai Ram M, Ilavazhagan G, Sharma SK, Dhanraj SA, Saresh B, Parida MM, Jan AM, Davendra K, Selvanmurthy W. Antimicrobial activity of a new vaginal contraceptive NIM. 76 from neem oil (Azadirachta indica). J Ethnopharmacol. 2000;1:377–82.
Sayet KA. Natural products as antiviral agents. Stud Nat Prod Chem. 2000;24:473–572.
Sidhu O, Kumar VP, Hari MB. Variability in triterpenoids (Nimbin and Salanin) composition of neem among different provenances of India. Ind Crops Prod. 2004;19:69–75.
Sim S, Ramirez JL, Dimopoulos G. Dengue virus infection of the Aedes aegypti salivary gland and chemosensory apparatus induces genes that modulate infection and blood-feeding behavior. PLoS Pathog. 2012;8:e1002631.
Subapriya R, Nagini S. Medicinal properties of neem leaves: a review. Curr Med Chem Anticancer Agents. 2005;5(2):149–56.
Tang LI, Ling AP, Koh RY, Chye SM, Voon KG. Screening of anti-dengue activity in methanolic extracts of medicinal plants. Bmc Complem Altern Med. 2012;12:3.
Tiwari V, Darmani NA, Yue BYUT, Shukla D. In vitro antiviral activity of neem (Azardirachta indica L.) bark extract against herpes simplex virus type-1 infection. Phytother Res. 2010;24:1132–40.
Upadhyay SN, Dhawan S, Garg S, Wali N, Tusker L, Anderson DJ. Immunomodulatory properties of neem. In: World Neem Conference: Bangalore, India. 1993 (p. abstract no. 80).
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability or drugs. J Med Chem. 2002;45:2615–23.
Wang QY, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, Poh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG. A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother. 2009;53:1823–31.
Williams FM. Clinical significance of esterases in man. Clin Pharmacokinet. 1985;10(5):392–403.
Zhang Y, Zhang W, Ogata S, Clements D, Strauss JH, Baker TS, Kuhn RJ, Rossman MJ. Conformational changes of the Flavivirus E glycoprotein. Structure. 2004;12(9):1607–8.